BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34604387)

  • 1. Influences of S100A8 and S100A9 on Proliferation of Nasopharyngeal Carcinoma Cells through PI3K/Akt Signaling Pathway.
    Wen L; Ding Y; Chen X; Tian K; Li D; Liang K; Yue B
    Biomed Res Int; 2021; 2021():9917365. PubMed ID: 34604387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXD3 inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma through regulation of the PI3K-Akt pathway.
    Xie X; Xiong G; Chen W; Fu H; Li M; Cui X
    Biochem Cell Biol; 2020 Dec; 98(6):653-660. PubMed ID: 32459973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of
    Yao LZ; Zhu YL; Liu JJ
    Technol Cancer Res Treat; 2020; 19():1533033820917959. PubMed ID: 32281513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of lncRNA MIR31HG promotes nasopharyngeal carcinoma cell proliferation and inhibits apoptosis through suppressing the PI3K/AKT signaling pathway.
    Feng B; Chen K; Zhang W; Zheng Q; He Y
    J Clin Lab Anal; 2022 Dec; 36(12):e24720. PubMed ID: 36347827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100A8 and S100A9 promote endothelial cell activation through the RAGE‑mediated mammalian target of rapamycin complex 2 pathway.
    Zhong X; Xie F; Chen L; Liu Z; Wang Q
    Mol Med Rep; 2020 Dec; 22(6):5293-5303. PubMed ID: 33174028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway.
    Huang Q; Hou S; Zhu X; Liu S
    World J Surg Oncol; 2020 Feb; 18(1):29. PubMed ID: 32013999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA ZFAS1 promotes proliferation and migration and inhibits apoptosis in nasopharyngeal carcinoma via the PI3K/AKT pathway in vitro.
    Wang X; Jin Q; Wang X; Chen W; Cai Z
    Cancer Biomark; 2019; 26(2):171-182. PubMed ID: 31403940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway.
    Zuo WN; Zhu H; Li LP; Jin AY; Wang HQ
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7935-7942. PubMed ID: 31599418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/β-catenin pathway.
    Duan L; Wu R; Ye L; Wang H; Yang X; Zhang Y; Chen X; Zuo G; Zhang Y; Weng Y; Luo J; Tang M; Shi Q; He T; Zhou L
    PLoS One; 2013; 8(4):e62092. PubMed ID: 23637971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of S100A8/S100A9 is inducible and regulated by the Hippo/YAP pathway in squamous cell carcinomas.
    Li Y; Kong F; Jin C; Hu E; Shao Q; Liu J; He D; Xiao X
    BMC Cancer; 2019 Jun; 19(1):597. PubMed ID: 31208368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-331-3p Inhibits Proliferation and Promotes Apoptosis of Nasopharyngeal Carcinoma Cells by Targeting elf4B-PI3K-AKT Pathway.
    Xuefang Z; Ruinian Z; Liji J; Chun Z; Qiaolan Z; Jun J; Yuming C; Junrong H
    Technol Cancer Res Treat; 2020; 19():1533033819892251. PubMed ID: 31984860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas9 based knockout of S100A8 in mammary epithelial cells enhances cell proliferation and triggers oncogenic transformation via the PI3K-Akt pathway: Insights from a deep proteomic analysis.
    Singh P; Ali SA; Kumar S; Mohanty AK
    J Proteomics; 2023 Sep; 288():104981. PubMed ID: 37544501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitinase 3 like-1 activates the Akt pathway, inducing NF-κB-dependent release of pro-inflammatory cytokines and promoting the proliferative ability in nasopharyngeal carcinoma cells.
    Li D; Fan G; Zhou Y
    Cytokine; 2024 Jul; 179():156631. PubMed ID: 38710115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saucerneol attenuates nasopharyngeal carcinoma cells proliferation and metastasis through selectively targeting Grp94.
    Cheng Y; Wang Q; Zhang Z; Zhao C; Zhou H; Xu J; Gu Q
    Phytomedicine; 2022 Jul; 101():154133. PubMed ID: 35504052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1.
    Basso D; Bozzato D; Padoan A; Moz S; Zambon CF; Fogar P; Greco E; Scorzeto M; Simonato F; Navaglia F; Fassan M; Pelloso M; Dupont S; Pedrazzoli S; Fassina A; Plebani M
    Cell Commun Signal; 2014 Mar; 12():20. PubMed ID: 24670043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of NOX4 on radiosensitivity of nasopharyngeal carcinoma cells by activating the PI3K/AKT pathway].
    Ning XH; Liu J; Hu L; Lu HY; Liu Q; Wang DH
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 May; 55(5):514-519. PubMed ID: 32842368
    [No Abstract]   [Full Text] [Related]  

  • 17. Squalene epoxidase-induced cholesteryl ester accumulation promotes nasopharyngeal carcinoma development by activating PI3K/AKT signaling.
    Li L; Zhang Q; Wang X; Li Y; Xie H; Chen X
    Cancer Sci; 2020 Jul; 111(7):2275-2283. PubMed ID: 32314495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell Proliferation and Apoptosis-Related Genes Affect the Development of Human Nasopharyngeal Carcinoma Through PI3K/AKT Signaling Pathway.
    Li W; Ma H; Liu M
    Mol Biotechnol; 2021 Nov; 63(11):1081-1091. PubMed ID: 34236626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-3612 targeting THBS1 suppresses nasopharyngeal carcinoma progression by PI3K/AKT signaling pathway.
    Zhang W; Zhang Q; Cui Q; Xu Y
    Hum Exp Toxicol; 2023; 42():9603271221150248. PubMed ID: 36607163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of lncRNA HAGLROS enhances the development of nasopharyngeal carcinoma via modulating miR-100/ATG14 axis-mediated PI3K/AKT/mTOR signals.
    Zhang W; Zhang Y; Xi S
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3043-3052. PubMed ID: 31334669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.